Modern Healthcare: The FDA is launching a review of its process to allow drug companies and other research entities to perform clinical testing on humans.
Under the investigational new drug, or IND, phase of drug development, researchers obtain permission to start human clinical trials. Once an IND is submitted, the FDA has 30 days to object, otherwise it automatically becomes effective and clinical trials may begin.
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now